Impact of the Newly-revised "Regulations for Lot Release of Biological Products" on Some Inspection Processes and Countermeasures

Xue Jing, Huang Qingquan, Zhang Jie

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (8) : 871-876.

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (8) : 871-876. DOI: 10.16153/j.1002-7777.2021.08.004
Supervision Administration

Impact of the Newly-revised "Regulations for Lot Release of Biological Products" on Some Inspection Processes and Countermeasures

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 35(8): 871-876 https://doi.org/10.16153/j.1002-7777.2021.08.004

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-7
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉